US FDA’s Gene Therapy Work Feeling The Effects Of Pandemic Response

Mobile Electronic Traffic Sign stating “expect Delays” taken at sunset with traffic blurred driving past the sign and traffic cones
US FDA's policy work in the gene therapy space has been delayed by the need to respond to the coronavirus pandemic. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Cell & Gene Therapies

More from Advanced Technologies